Research Article
Genetic Background of Immune Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children
Table 1
The indications for HSCT (pre-HSCT group).
| | Condition | (%) |
| | Acute lymphoblastic leukemia (ALL) | 15 (36) | | Acute myeloblastic leukemia (AML) | 5 (15) | | Acute bilineage leukemia (ABL) | 1 (3) | | Juvenile myelomonocytic and acute myeloblastic leukemia (JMML/AML) | 1 (3) | | Myelodysplastic syndrome (MDS) | 1 (3) | | Neoplasms (total) | 23 (70) | | Severe aplastic anemia (SAA) | 4 (12) | | Chronic granulomatous disease (CGD) | 3 (9) | | Autoimmune lymphoproliferative syndrome (ALPS) | 1 (3) | | Hyper-IgM syndrome (HIgM) | 1 (3) | | Inherited neutropenia (IN) | 1 (3) | | Nonneoplastic conditions (total) | 10 (30) |
|
|
